| Wed, Nov 26, 2008 | | • | Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease
PR Newswire (Wed, Nov 26)
| | Wed, Nov 19, 2008 | | • | Cell Genesys, Inc. Q3 2008 Earnings Call Transcript
at Seeking Alpha (Wed, Nov 19)
| | Thu, Nov 13, 2008 | | • | CELL GENESYS INC Financials
EDGAR Online Financials (Thu, Nov 13)
| | Tue, Nov 11, 2008 | | • | Zacks #1 Rank Additions for Tuesday
Zacks.com (Tue, Nov 11)
| | Sun, Nov 9, 2008 | | • | New Star Analyst Rankings for CELL GENESYS INC
StarMine (Sun, Nov 9)
| | Fri, Nov 7, 2008 | | • | Cell Genesys Announces "Modified Dutch Auction" Tender Offer for up to $80 Million Aggregate Principal Amount of Its Convertible Debt Securities
Business Wire (Fri, Nov 7)
| | Thu, Nov 6, 2008 | | • | Cell Genesys Earnings Call scheduled for 4:30 pm ET today
CCBN (Thu, Nov 6)
| | • | CELL GENESYS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Nov 6)
| | • | Cell Genesys Reports Third Quarter 2008 Financial Results
Business Wire (Thu, Nov 6)
| | • | Q3 2008 Cell Genesys Earnings Release - Time Not Supplied
CCBN (Thu, Nov 6)
| | Wed, Nov 5, 2008 | | • | Cell Genesys to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
Business Wire (Wed, Nov 5)
| | Tue, Nov 4, 2008 | | • | Ceregene Phase 2 Clinical Trial for Alzheimer's Disease to be Funded by $5.4 Million Grant From National Institutes of Health
PR Newswire (Tue, Nov 4)
| | Thu, Oct 30, 2008 | | • | Cell Genesys to Webcast Third Quarter 2008 Conference Call
Business Wire (Thu, Oct 30)
| | Fri, Oct 24, 2008 | | • | CELL GENESYS INC Files SEC form 8-K, Other Events
EDGAR Online (Fri, Oct 24)
| | • | [$$] Biotech Mailbag: Lessons From Clinical Trials
at RealMoney by TheStreet.com (Fri, Oct 24)
| | Thu, Oct 23, 2008 | | • | Do These Stocks Deserve Your Support?
at Motley Fool (Thu, Oct 23)
| | Wed, Oct 22, 2008 | | • | Nasdaq suspends some listing rules
at bizjournals.com (Wed, Oct 22)
| | • | CELL GENESYS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard;
EDGAR Online (Wed, Oct 22)
| | • | Cell Genesys Announces Receipt of Nasdaq Staff Deficiency Notice Relating to Non-Compliance With a Nasdaq Stock Market Listing Requirement
Business Wire (Wed, Oct 22)
| | Mon, Oct 20, 2008 | | • | Don't Get Burned by the Next Cell Genesys
at TheStreet.com (Mon, Oct 20)
|
Add CEGE News to My Yahoo!:
 
| |
|
6.97% Nasdaq 
Headlines
